Structure Therapeutics Inc.

NasdaqGM GPCR

Structure Therapeutics Inc. Market Capitalization on January 14, 2025: USD 1.45 B

Structure Therapeutics Inc. Market Capitalization is USD 1.45 B on January 14, 2025, a -39.93% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Structure Therapeutics Inc. 52-week high Market Capitalization is USD 3.22 B on June 05, 2024, which is 121.83% above the current Market Capitalization.
  • Structure Therapeutics Inc. 52-week low Market Capitalization is USD 1.44 B on January 13, 2025, which is -0.87% below the current Market Capitalization.
  • Structure Therapeutics Inc. average Market Capitalization for the last 52 weeks is USD 2.19 B.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
NasdaqGM: GPCR

Structure Therapeutics Inc.

CEO Dr. Raymond C. Stevens Ph.D.
IPO Date Feb. 3, 2023
Location United States
Headquarters 611 Gateway Boulevard
Employees 136
Sector Health Care
Industries
Description

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist, targeting apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension; and LTSE-2578, an investigational oral small molecule lysophosphatidic acid 1 receptor antagonist for the treatment of IPF. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was founded in 2016 and is headquartered in South San Francisco, California.

Similar companies

IRON

Disc Medicine, Inc.

USD 57.83

-1.55%

BMEA

Biomea Fusion, Inc.

USD 4.15

0.00%

HOOK

HOOKIPA Pharma Inc.

USD 1.86

4.49%

INZY

Inozyme Pharma, Inc.

USD 1.51

-12.21%

MREO

Mereo BioPharma Group plc

USD 3.06

-8.38%

TERN

Terns Pharmaceuticals, Inc.

USD 4.57

-4.79%

ELDN

Eledon Pharmaceuticals, Inc.

USD 3.71

-4.63%

ABOS

Acumen Pharmaceuticals, Inc.

USD 1.56

-1.89%

DAWN

Day One Biopharmaceuticals, Inc.

USD 11.16

-3.46%

AMLX

Amylyx Pharmaceuticals, Inc.

USD 3.13

-1.57%

StockViz Staff

January 15, 2025

Any question? Send us an email